STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Statement [Abstract]
GRANT INCOME AND OTHER	$ 20,976	$ 136,838
OPERATING EXPENSES:
Research and development (excluding R&D depreciation of $28,309 and $43,159 respectively, included below)	5,141,198	4,854,821
Depreciation and amortization	41,741	56,613
General & administrative	621,169	5,221,145
Total operating expenses	5,804,108	10,132,579
OPERATING LOSS	(5,783,132)	(9,995,741)
GAIN ON DERIVATIVE INSTRUMENTS	8,122,960	2,162,970
INTEREST INCOME (EXPENSE), NET	1,985	(12,547)
NET INCOME (LOSS) AVAILABLE TO COMMON SHAREHOLDERS	$ 2,341,813	$ (7,845,318)
NET INCOME (LOSS) PER COMMON SHARE
BASIC	$ 0.02	$ (0.11)
DILUTED	$ 0.02	$ (0.14)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
BASIC	109,768,502	73,260,783
DILUTED	111,639,785	73,260,783